Sensitivity and Responsiveness of Glucose Output to Insulin in Isolated Perfused Liver from Dexamethasone-Treated Rats

Summary

To elucidate insulin action on hepatic glucose output (glycogenolysis) in the state exposed to an excess glucocorticoid, the fed rat liver was isolated and cyclically perfused with a medium containing 5 mM glucose and various concentrations of insulin. The rat was subcutaneously injected with 1 mg/kg of dexamethasone (Dex) for 7 days. Dex-treated rats showed marked increases of serum insulin and plasma glucose level compared with those in control rats. Hepatic glycogen contents in Dex group were markedly increased compared with those in control (115 ± 5 and 28 ± 4 mg/g, respectively). Insulin extraction rate in the perfused liver was not different between control and Dex group.

Perfusate glucose level after 60 min perfusion was much higher in the Dex-treated rat liver than that of the control at 0 μU/ml insulin (34.5 ± 2.5 vs 23.0 ± 2.0 mM, P < 0.01), and reduced to the nadir level (19.0 ± 3.0 and 13.0 ± 1.5 mM, respectively) at 100 μU/ml insulin in both groups, i. e., the decreasing rate in perfusate glucose level was not different between Dex and control group (43% and 44%, respectively).

These results suggest that Dex-treatment augments hepatic glucose output, but does not affect the sensitivity and responsiveness of that to insulin.

Key words

Dexamethasone - Insulin - Liver Glycogen